XML 82 R70.htm IDEA: XBRL DOCUMENT v3.21.4
BUSINESS COMBINATIONS - Preliminary fair value of assets acquired and liabilities assumed (Details) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 01, 2019
Pre-Clinical Research Services, Inc.    
Assets acquired and liabilities assumed:    
Accounts receivable $ 578  
Property and equipment 2,836  
Unbilled revenues 162  
Prepaid expenses 27  
Intangible asset 2,081 $ 5,857
Goodwill (ii) 751  
Accounts payable (109)  
Accrued expenses (118)  
Customer advances (351)  
Total 5,857  
HistoTox Labs    
Assets acquired and liabilities assumed:    
Accounts receivable 982  
Property and equipment 4,021  
Unbilled revenues 337  
Operating lease ROU asset (i) 2,239  
Intangible asset 8,500  
Other assets 25  
Goodwill (ii) 9,129  
Accounts payable (132)  
Accrued expenses (266)  
Customer advances (207)  
Operating lease liability (i) (2,239)  
Total 22,389  
Bolder BioPATH    
Assets acquired and liabilities assumed:    
Accounts receivable 2,258  
Property and equipment 6,609  
Unbilled revenues 1,798  
Prepaid expenses 6  
Operating lease ROU asset (i) 2,750  
Intangible asset 12,500  
Other assets 70  
Goodwill (ii) 36,223  
Accounts payable (159)  
Accrued expenses (294)  
Deferred revenue (662)  
Deferred tax liability (4,867)  
Operating lease liability (i) (2,750)  
Total 53,482  
Gateway Pharmacology Laboratories LLC    
Assets acquired and liabilities assumed:    
Accounts receivable 422  
Property and equipment 359  
Operating lease ROU asset (i) 120  
Intangible asset 100  
Other assets 9  
Goodwill (ii) 2,207  
Accounts payable (54)  
Accrued expenses (72)  
Deferred tax liability (118)  
Operating lease liability (i) (120)  
Total 2,853  
BioReliance Corporation    
Assets acquired and liabilities assumed:    
Property and equipment 175  
Intangible asset 640  
Total $ 815